RUA Life Sciences has announced the acquisition of Analytic Biosurgical Solutions SAS (Abiss), a manufacturer of medical devices used for the treatment of female Stress Urinary Incontinence (SUI). RUA Life Sciences will pay €80,000 (c£67,000) cash for the business, which is being acquired from the French liquidator of IPSA SAS, the former parent company of Abiss. Notably, while the parent company went into insolvent liquidation in June 2021, Abiss was not placed in receivership/liquidation and h ....
